News

Medbase and Hirslanden launching healthcare portal with other partners

Together with two other partners from the Greater Zurich Area and Groupe Mutuel, Hirslanden and Medbase are launching a digitally supported healthcare ecosystem. The healthtech project Compassana enables users to arrange personal healthcare.

Medbase is part of the new health ecosystem with which various providers want to better coordinate medical care.
Medbase is part of the new health ecosystem with which various providers want to better coordinate medical care. Image Credit: Medbase

According to a press release issued by Hirslanden AG, the Hirslanden Group from Opfikon in the canton of Zurich has drawn up plans to develop a digitally supported healthcare ecosystem together with the Medbase Group, a healthcare service provider from Winterthur, the health insurance firm Groupe Mutuel based in Martigny in the canton of Valais, Helsana from Dübendorf in the canton of Zurich and Swica located in Winterthur. To this end, the four partners based in the Greater Zurich Area and Groupe Mutuel have founded the joint venture Bluespace Ventures AG, which is headquartered in Winterthur. The healthtech project Compassana is open to all stakeholders in the healthcare sector.

“Our intention is to sustainably change the healthcare system for the better, making it more straightforward and efficient”, explains Marcel Napierala, CEO of Medbase and Chair of the Board of Directors at Bluespace Ventures AG, before adding: “We believe this can only be achieved when players from different areas within the healthcare sector come together to develop joint, innovative solutions”.

The press release explains that the centerpiece of Compassana is a portal that customers can use to independently coordinate their healthcare. “Compassana will offer much more than basic digital services including checking symptoms, making appointments, and medical consultations over the phone”, comments Peter Mittemeyer in the press release. In this context, the CEO of Bluespace Ventures AG cites “digitally supported and medically optimized treatment or therapy options for general medical conditions”. The market entry of Compassana is expected to be finalized during the course of this year.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Share

Official program